- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Heated oral arguments at SCOTUS hint at Sanofi-Regeneron edge over Amgen in patent spat | ||
| Mo | Merck KGaA takes back control of PD-L1 cancer drug as Pfizer alliance ends | ||
| Mo | Eli Lilly to increase investment to $1B into new Irish manufacturing facility - report | ||
| Mo | Senator asks FTC to investigate AmerisourceBergen over abortion pill distribution plans | ||
| Mo | Resilience notches $410M in federal financing to bolster production | ||
| Mo | BioNTech readies for plunge in Covid sales, will boost mRNA and oncology pipelines | ||
| Mo | Gamida Cell makes more staff cuts and restructures as it focuses on potential drug launch | ||
| Mo | Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality | ||
| Mo | Jounce nixes Redx offer as I/O biotech instead goes with Concentra Biosciences' takeover bid | ||
| Mo | Who's spending and who's cutting from Big Pharma's $127B R&D budget? Here are the top 15 players | ||
| Mo | AstraZeneca, Ionis boast full PhIII win for ATTR drug under review | ||
| Mo | Codiak files for Chapter 11 bankruptcy as most executives head for the exit | ||
| Mo | Announcing three exciting journalists who are joining the Endpoints newsroom | ||
| Mo | Labviva nets $20M Series A to ease life science procurement process | ||
| Mo | With one of biotech's largest private rounds in a year, ArriVent enters PhIII | ||
| Mo | A career in cancer research turns out to be the perfect prep for a grueling personal adventure | ||
| Mo | Another biotech startup runs into a PhII pileup in Parkinson's | ||
| Mo | BrainStorm gets FDA adcomm for ALS drug after failed trial and RTF | ||
| Mo | Venture investing without the GSK tie-up? Simeon George and the SR One team score a $600M fund to pave the way forward | ||
| Sa | Latest on ultra-rare disease approval; Positive, if mixed, signs for Biogen's ALS drug; Clay Siegall finds a new job; and more | ||
| Fr | FDA approves Pharming drug for ultra-rare immunodeficiency disease | ||
| Fr | European doctors dial up digital communication with pharmas, but still lean toward in-person med meetings, study finds | ||
| Fr | Judge allows expert testimony in GSK trial alleging Zantac link to cancer | ||
| Fr | Q&A: BioCina's new CEO Mark Womack on the CDMO he says is 'worth traveling over' | ||
| Fr | Novo Nordisk oral semaglutide trial shows reduction in blood sugar, plus weight loss |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
